JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsopelas, C.
Right arrow Articles by Sutton, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsopelas, C.
Right arrow Articles by Sutton, R.
Journal of Nuclear Medicine Vol. 43 No. 10 1377-1382
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Why Certain Dyes Are Useful for Localizing the Sentinel Lymph Node

Chris Tsopelas, PhD1 and Richard Sutton, MB BS2

1 Royal Adelaide Hospital, Nuclear Medicine Department, RAH Radiopharmacy, Adelaide, South Australia, Australia
2 Department of Academic Surgery, Royal Marsden Hospital, London, United Kingdom

Location of the sentinel lymph node in malignant melanoma and early breast cancer patients requires separate injections of radiocolloid and blue dye. These agents are administered at alternative times because of their different rates of transit. This study has elucidated why particular dyes are absorbed by the lymphatic system from an investigation of dye molecular structure as a function of protein binding ability. Methods: A dye-protein binding assay was developed using size-exclusion chromatography and ultraviolet spectrophotometry and applied to a series of 20 sulfonic acid group-containing dyes. Radiochemical analyses were also used with 3 99mTc-labeled dyes to rationalize which functional groups are involved in the protein binding reaction. Results: Methylene blue resulted in no protein affinity at 37°C, whereas disulfonate dyes separated by 1 atom such as Patent blue or Indigo carmine gave <30% binding. Optimum protein binding (84%–100%) was achieved with those dyes containing at least 2 sulfonic acid groups separated by 2–6 atoms in their chemical structure. Seven symmetric tetrasulfonic acid azo dyes were examined, including Evans blue, to result in 59%–71% binding. Conclusion: Ionizable groups (sulfonic acids) that are present in the structure of dyes are directly involved in dye-protein binding. At the molecular level, there is a sulfonation reaction between sulfonic acid dyes and amino groups on the protein surface to form sulfonamide complexes. This reaction shows how the soluble dyes Evans blue and Patent blue are trapped in lymph after subdermal injection during the sentinel node biopsy procedure.

Key Words: sentinel node biopsy • blue dye • protein binding mechanism • sulfonic acid group




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
C. Tsopelas, E. Bevington, J. Kollias, S. Shibli, G. Farshid, B. Coventry, and B. E. Chatterton
99mTc-Evans Blue Dye for Mapping Contiguous Lymph Node Sequences and Discriminating the Sentinel Lymph Node in an Ovine Model
Ann. Surg. Oncol., May 1, 2006; 13(5): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. Pinero, J. Illana, C. Garcia-Palenciano, F. Canizares, M. Canteras, V. Canadillas, E. Duran, and P. Parrilla
Effect on Oximetry of Dyes Used for Sentinel Lymph Node Biopsy: Are There Differences?
Arch Surg, November 1, 2004; 139(11): 1204 - 1207.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. S. Wilbur, C. Tsopelas, and R. Sutton
Formation of Sulfonamide Bonds Through Reaction of Dyes with Serum Proteins
J. Nucl. Med., September 1, 2003; 44(9): 1540 - 1541.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.